Digital Health Investors & VC Firms in China
67 firms in this list, with a median first check of $1.1M. 11 of them lead rounds. Generated from verified public data and updated continuously.
Shiyu Capital
HainanSeed–Late Stage
Zhejiang Paradise
HangzhouSeed
3H Health Investment
ShanghaiSeries A–Late Stage
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
72 people
F-Prime Capital
CambridgePre-Seed–Late Stage$3M – $10M
110 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
47 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
30 people
Tenaya Capital
Palo AltoSeries A–Late Stage$5M – $10M
8 people
Eight Roads Ventures
MumbaiSeed–Late Stage$5M – $30M
20 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
22 people
Goodwater Capital
BurlingamePre-Seed–Late Stage$5M – $50M
13 people
Decheng Capital
Menlo ParkSeed–Growth
19 people
Panacea Venture
SingaporePre-Seed–Late Stage
22 people
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
7 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Ventech
ParisSeed–Growth$540K – $5.4M
10 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
21 people
Pix Vine Capital
SingaporeSeed–Series A$250K – $500K
1 person
LYFE Capital
Menlo ParkSeed–Late Stage
16 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
BlueRun Ventures
San FranciscoSeed–Series A$1M – $6M
9 people
Pivotal Life Sciences
San FranciscoSeed–Late Stage
14 people
NSG Ventures
SingaporeSeed–Series A
10 people
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.
















































































